Literature DB >> 11709404

No involvement of nitric oxide in the limitation of beta-adrenergic inotropic responsiveness during ischemia.

H Post1, R Schulz, P Gres, G Heusch.   

Abstract

We tested whether or not endogenous nitric oxide (NO) attenuates beta-adrenergic inotropic responsiveness during normoperfusion or moderate myocardial ischemia. In 13 anesthetized pigs with a cannulated left anterior descending (LAD) coronary artery, the maximal contractile responses to intracoronary dobutamine and calcium were assessed during normoperfusion and at the end of a 90-min period of moderate ischemia (50% reduction in coronary arterial inflow) without (group 1, n = 6) and with (group 2, n = 7) prior inhibition of NO synthesis [30 mg/kg iv N(omega)-nitro-L-arginine (L-NNA)]. Contractile function was assessed by a regional work index (sonomicrometry, micromanometry, mm. mmHg). In groups 1 and 2 during normoperfusion, the maximal increase of the work index was greater with calcium than with dobutamine. At the end of ischemia in group 1, the baseline work index was decreased by approximately 50%, and the subsequent maximal increase of the work index with dobutamine, but not with calcium, was reduced compared with normoperfusion. In group 2 during normoperfusion, L-NNA did not alter the maximal increases of the work index with dobutamine or calcium. At the end of ischemia, the baseline work index was reduced by 64%, and the subsequent maximal increases of the work index with both dobutamine and calcium were reduced compared with normoperfusion; however, the response to calcium was still greater than that to dobutamine. We conclude that endogenous NO does not limit beta-adrenergic inotropic responsiveness in normoperfused or moderately ischemic porcine myocardium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709404     DOI: 10.1152/ajpheart.2001.281.6.H2392

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  10 in total

1.  Nitric oxide and myocardial function in heart failure: friend or foe?

Authors:  J M Cotton; M T Kearney; A M Shah
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

Review 2.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

3.  ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes.

Authors:  Ji Hyun Jang; Jung Nyeo Chun; Shigeo Godo; Guangyu Wu; Hiroaki Shimokawa; Chun Zi Jin; Ju Hong Jeon; Sung Joon Kim; Zhe Hu Jin; Yin Hua Zhang
Journal:  Basic Res Cardiol       Date:  2015-03-25       Impact factor: 17.165

4.  Neuronal nitric oxide synthase is indispensable for the cardiac adaptive effects of exercise.

Authors:  Steve R Roof; Lifei Tang; Joseph E Ostler; Muthu Periasamy; Sandor Györke; George E Billman; Mark T Ziolo
Journal:  Basic Res Cardiol       Date:  2013-02-04       Impact factor: 17.165

5.  Reduced left ventricular compliance and mechanical efficiency after prolonged inhibition of NO synthesis in conscious dogs.

Authors:  Heiner Post; Chiara d'Agostino; Vincenzo Lionetti; Michele Castellari; Elaine Y Kang; Martin Altarejos; Xiaobin Xu; Thomas H Hintze; Fabio A Recchia
Journal:  J Physiol       Date:  2003-07-23       Impact factor: 5.182

6.  Endothelial NOS (NOS3) impairs myocardial function in developing sepsis.

Authors:  Annette M van de Sandt; Rainer Windler; Axel Gödecke; Jan Ohlig; Simone Zander; Michael Reinartz; Jürgen Graf; Ernst E van Faassen; Tienush Rassaf; Jürgen Schrader; Malte Kelm; Marc W Merx
Journal:  Basic Res Cardiol       Date:  2013-02-10       Impact factor: 17.165

7.  Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure.

Authors:  Sanja S Soskić; Branislava D Dobutović; Emina M Sudar; Milan M Obradović; Dragana M Nikolić; Jelena D Djordjevic; Djordje J Radak; Dimitri P Mikhailidis; Esma R Isenović
Journal:  Open Cardiovasc Med J       Date:  2011-07-07

Review 8.  Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases.

Authors:  Enrico Lupia; Alberto Goffi; Ornella Bosco; Giuseppe Montrucchio
Journal:  Mediators Inflamm       Date:  2012-04-05       Impact factor: 4.711

9.  New perspectives of nitric oxide donors in cardiac arrest and cardiopulmonary resuscitation treatment.

Authors:  Peter Kruzliak; Olga Pechanova; Tomas Kara
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

10.  Cardiomyocyte depolarization triggers NOS-dependent NO transient after calcium release, reducing the subsequent calcium transient.

Authors:  Matias Mosqueira; Roland Konietzny; Carolin Andresen; Chao Wang; Rainer H A Fink
Journal:  Basic Res Cardiol       Date:  2021-03-17       Impact factor: 17.165

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.